Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd (4581.T) is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's (BMY.N) French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,